
$89.5B+34% YoYFY 2025
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Revenue reached $89.5B in 2025, compounding +10% a year since 2022 though the path has been bumpy. The trailing twelve months are already running at $94.0B, ahead of the last full year.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
$2.2BFY 2025
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Net income was $2.2B in 2025, against $-11.8B the year before. Trailing twelve-month profit stands at $2.4B.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
+34.5%revenue growth, FY 2025
→Revenue grew +34% in 2025 against a five-year average of +10%.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
$-1.9BFY 2025
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→The business consumed $1.9B of cash in 2025 after investment. Growth is being funded from the balance sheet, not from operations.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→Of $89.5B in 2025 sales, $2.2B reaches net profit - 2 cents on the dollar. The largest single deduction is producing the product ($85.2B).
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Free cash flow is negative, so no share of revenue is currently converting to spare cash. Every sales dollar is being reinvested or consumed.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year
→The biggest claim on each sales dollar is research and development, at 4% of revenue (capital spending 3%, stock compensation 0%).
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→Operating profit outgrew revenue in only 2 of the last 5 years. Costs are growing roughly in step with the business, so scale isn't yet paying for itself.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year
→Operating margin widened 10 points to 5% since 2022. After everything, 2 cents of each sales dollar reaches net profit.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year
→ROE of 40% sits well above ROCE of 7%. A meaningful share of the shareholder return is manufactured with leverage rather than operations.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
66.4xP/E today
◌ 2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages
→At 66.4x earnings, the market is paying +290% more than BA's own 5-year median of 17.0x. Expectations are elevated, so more has to go right to justify the price.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
-0.1%FCF yield today
◌ 2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages
→Every dollar of market value currently buys -0.1% of annual free cash flow, less than its 11-year median of 2.3% - you are paying up for the same cash.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→Debt of $50.2B sits against $7.2B of cash, or 8.2x shareholders' equity.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→The company's own capital grew from $-17.2B in 2023 to $6.1B. The business is building book value rather than consuming it.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→Shareholders received $2.7B in buybacks and $331M in dividends in 2019. Stock compensation issued $426M of new shares in the same year, offsetting 14% of that.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→The share count grew 17.8% in 2025, averaging 8.8% a year over three years. Your slice of the company shrinks by that much each year unless earnings grow faster.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→The dividend per share reached $0.43 in 2025, compounding -27% a year since 2020.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year
→The dividend consumed 15% of profit and 29% of free cash flow in 2025. That leaves room to keep paying through a weak year.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→BA earns 7.1% on the capital it employs, below the 10% most investors treat as the cost of capital.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→BA issued +2% more shares from 2011 to 2025, but revenue per share still rose +28%. The dilution bought more growth than it cost existing holders.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→Insiders bought $799,311 and sold $351,484 on the open market, a net purchase of $447,827. A further 15 filings were grants, option exercises or tax withholding, which say nothing either way.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30